Covid vaccine likely to be ready by end of 2020, final pricing in 2 months: SII

1 min read
vaccine 1
Representational picture

Adar Poonawalla, Chief Executive Officer of Pune-based Serum Institute of India (SII), has said the coronavirus vaccine may be ready by the end of this year and that the final price of the anti-virus dose will be announced in two months.

SII is part of an agreement with AstraZeneca, which along with Oxford University, has developed a vaccine that has reported satisfactory progress from the test results.

“We should have a vaccine by the end of this year. We will conduct trials in India on a few thousand patients in partnership with the Indian Council of Medical Research (ICMR),” Poonawalla told CNBC-TV18, adding the final pricing for the vaccine will be announced in two months.

Poonawalla had earlier said that by the end of August, between 4,000 to 5,000 people in Pune and Mumbai will be injected with the vaccine as part of trials scheduled to last over two month. He said the company aims to manufacture 300 million to 400 million doses by the year-end.

Don't Miss

2022 12img21 Dec 2022 PTI12 21 2022 000141A 1

Use masks in crowded places, take precaution dose of Covid vaccine: NITI Aayog member

NEW DELHI, Dec 21: Only 27-28 per cent of India’s eligible population
Screenshot 2022 09 01 123408

`qHPV’: India to roll out first indigenously developed vaccine against Cervical Cancer today

NEW DELHI: Serum Institute of India (SII) and the Department of Biotechnology(DBT)